Overview
Description
Camp4 Therapeutics Corp. is a biotechnology company focused on developing innovative therapeutics by unlocking the potential of gene regulation. The company's core mission is to harness the knowledge of transcriptional machinery and regulatory RNA maps, pioneering in the precision medicine landscape. Camp4 Therapeutics targets a wide array of conditions, primarily genetically driven diseases, by delicately manipulating gene expression to restore normal cellular function. The firm's approach uniquely positions it to impact the broader healthcare and pharmaceutical industries significantly. By translating cutting-edge genomic insights into actionable therapeutic strategies, Camp4 aims to address unmet medical needs and enhance patient outcomes. The company's progress and pipeline developments are closely watched by stakeholders, reflecting its potential to contribute meaningfully to the biotech sector and ultimately, patient care.
About
CEO
Mr. Joshua Mandel-Brehm
Employees
55
Address
One Kendall Square
3rd Floor Building 1400 West
Cambridge, 02139, MA
United States
3rd Floor Building 1400 West
Cambridge, 02139, MA
United States
Phone
617-651-8867
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNMS